ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,275.38
0.54%
Dow Jones
38,686.32
1.51%
Gold vs US Dollar
2,327.355
0.00%
Brent Oil
81.295
0.00%
Bitcoin
67,663.96
0.27%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Mersana Therapeutics Inc (MRSN)

  7. Mersana Therapeutics Inc (MRSN) News

Mersana Therapeutics (MRSN)

Mersana Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:MRSN
DateTimeSourceHeadlineSymbolCompany
22/05/202413:00GlobeNewswire Inc.Mersana Therapeutics to Present at Upcoming Investor ConferencesNASDAQ:MRSNMersana Therapeutics Inc
17/05/202413:26Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:MRSNMersana Therapeutics Inc
10/05/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:MRSNMersana Therapeutics Inc
09/05/202422:06Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:MRSNMersana Therapeutics Inc
09/05/202414:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MRSNMersana Therapeutics Inc
09/05/202412:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MRSNMersana Therapeutics Inc
09/05/202411:59GlobeNewswire Inc.Mersana Therapeutics Provides Business Update and Announces First Quarter 2024 Financial ResultsNASDAQ:MRSNMersana Therapeutics Inc
03/05/202421:30GlobeNewswire Inc.Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:MRSNMersana Therapeutics Inc
02/05/202413:00GlobeNewswire Inc.Mersana Therapeutics to Host First Quarter 2024 Conference Call on May 9, 2024NASDAQ:MRSNMersana Therapeutics Inc
04/04/202421:30GlobeNewswire Inc.Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:MRSNMersana Therapeutics Inc
28/02/202421:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MRSNMersana Therapeutics Inc
28/02/202421:07Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:MRSNMersana Therapeutics Inc
28/02/202421:05Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:MRSNMersana Therapeutics Inc
28/02/202413:49Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:MRSNMersana Therapeutics Inc
28/02/202413:43Edgar (US Regulatory)Form POSASR - Post-effective Amendment to an automatic shelf registration statementNASDAQ:MRSNMersana Therapeutics Inc
28/02/202412:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MRSNMersana Therapeutics Inc
28/02/202412:00GlobeNewswire Inc.Mersana Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:MRSNMersana Therapeutics Inc
27/02/202413:01GlobeNewswire Inc.Mersana Therapeutics to Present at Upcoming Investor ConferencesNASDAQ:MRSNMersana Therapeutics Inc
21/02/202413:00GlobeNewswire Inc.Mersana Therapeutics to Host Fourth Quarter and Year End 2023 Conference Call on February 28, 2024NASDAQ:MRSNMersana Therapeutics Inc
16/02/202421:30Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:MRSNMersana Therapeutics Inc
15/02/202401:56Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:MRSNMersana Therapeutics Inc
15/02/202401:43Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:MRSNMersana Therapeutics Inc
14/02/202414:20Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:MRSNMersana Therapeutics Inc
01/02/202413:00GlobeNewswire Inc.Mersana Therapeutics to Participate in Guggenheim’s 6th Annual Biotechnology ConferenceNASDAQ:MRSNMersana Therapeutics Inc
17/01/202422:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRSNMersana Therapeutics Inc
17/01/202422:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRSNMersana Therapeutics Inc
17/01/202422:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRSNMersana Therapeutics Inc
17/01/202422:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRSNMersana Therapeutics Inc
17/01/202422:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRSNMersana Therapeutics Inc
17/01/202422:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRSNMersana Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:MRSN

Your Recent History

NYSE
KKR-A
KKR
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved